These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24748582)

  • 1. Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients.
    Bauters T; Rayner P; Therrien R; Van Lancker S; Bordon V; Le Cordroch M; Dhooge C; Benoit Y; Vandenbroucke J
    J Oncol Pharm Pract; 2015 Dec; 21(6):478-80. PubMed ID: 24748582
    [No Abstract]   [Full Text] [Related]  

  • 2. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
    Oshima K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Kanda Y
    Bone Marrow Transplant; 2010 Apr; 45(4):781-2. PubMed ID: 19701249
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation.
    Butts AR; Brown VT; McBride LD; Bolaños-Meade J; Bryk AW
    J Oncol Pharm Pract; 2016 Apr; 22(2):275-83. PubMed ID: 25802301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdisciplinary implementation of tacrolimus intravenous standard concentration in hematopoietic stem cell transplantation recipients.
    Shank BR; Deaver M; Baker A; Myers AL; Zhang YP; Anderegg B; Bassett R; Westmoreland M
    J Oncol Pharm Pract; 2018 Jul; 24(5):365-370. PubMed ID: 28554241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus in hematopoietic stem cell transplantation.
    Fortune K; Couriel D
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):835-41. PubMed ID: 19545215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in adult hematopoietic stem cell transplantation.
    Gao Y; Ma J
    Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):803-811. PubMed ID: 31595800
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation].
    Yuda S; Mori T; Kato J; Koda Y; Kohashi S; Kikuchi T; Saburi M; Okamoto S
    Rinsho Ketsueki; 2013 Dec; 54(12):2187-91. PubMed ID: 24452151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients.
    Yamazaki R; Mori T; Aisa Y; Kato J; Nakamura Y; Nakazato T; Mihara A; Ikeda Y; Okamoto S
    Transplant Proc; 2009 Jun; 41(5):1831-3. PubMed ID: 19545738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.
    Kakihana K; Ohashi K; Murata Y; Tsubokura M; Kobayashi T; Yamashita T; Sakamaki H; Akiyama H
    Bone Marrow Transplant; 2012 Apr; 47(4):593-5. PubMed ID: 21625227
    [No Abstract]   [Full Text] [Related]  

  • 10. [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation].
    Hosonuma R; Fujiwara S; Sasazaki M; Hirata Y; Yamamoto C; Uesawa M; Oh I; Matsuyama T; Mori M; Ozawa K; Muroi K
    Rinsho Ketsueki; 2012 Apr; 53(4):469-71. PubMed ID: 22687983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
    Bacopoulos AJ; Ho L; Yang A; Ng P; Dara C; Loach D; Deotare U; Michelis FV; Viswabandya A; Kim DD; Lipton JH; Messner HA; Thyagu S
    J Oncol Pharm Pract; 2021 Jan; 27(1):33-39. PubMed ID: 32183586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?
    William BM; de Lima M
    Leuk Lymphoma; 2015 Mar; 56(3):555-6. PubMed ID: 25065702
    [No Abstract]   [Full Text] [Related]  

  • 13. Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease.
    Conrotto D; Carrozzo M; Ubertalli AV; Gandolfo S; Giaccone L; Boccadoro M; Bruno B
    Transplantation; 2006 Oct; 82(8):1113-5. PubMed ID: 17060865
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation.
    Kida A; Ohashi K; Tanaka C; Kamata N; Akiyama H; Sakamaki H
    Br J Haematol; 2004 Aug; 126(3):288. PubMed ID: 15257699
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical considerations in the use of tacrolimus for allogeneic marrow transplantation.
    Przepiorka D; Devine S; Fay J; Uberti J; Wingard J
    Bone Marrow Transplant; 1999 Nov; 24(10):1053-6. PubMed ID: 10578154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reaction to intravenous but not oral tacrolimus.
    Nicolai S; Bunyavanich S
    Transplantation; 2012 Nov; 94(9):e61-3. PubMed ID: 23128975
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
    Fujii N; Ikeda K; Koyama M; Aoyama K; Masunari T; Kondo E; Matsuzaki T; Mizobuchi S; Hiraki A; Teshima T; Shinagawa K; Ishimaru F; Tanimoto M
    Int J Hematol; 2006 Jun; 83(5):459-61. PubMed ID: 16787880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Factors Affecting the Dose Conversion Ratio from Intravenous to Oral Tacrolimus Formulation among Pediatric Hematopoietic Stem Cell Transplantation Recipients.
    Kanamitsu K; Yorifuji T; Ishida H; Fujiwara K; Washio K; Shimada A; Tsukahara H
    Ther Drug Monit; 2020 Dec; 42(6):803-810. PubMed ID: 32732549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.
    Mori T; Kato J; Shimizu T; Aisa Y; Nakazato T; Yamane A; Ono Y; Kunimoto H; Okamoto S
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):229-34. PubMed ID: 21708109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children.
    Kanekiyo T; Hara J; Matsuda-Hashii Y; Fujisaki H; Tokimasa S; Sawada A; Kubota K; Shimono K; Imai K; Ozono K
    Int J Hematol; 2005 Apr; 81(3):264-8. PubMed ID: 15814339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.